Systemic Implications and Complications The risk of malignant melanoma arising within a congenital melanocytic nevus is established most clearly for patients with large CMN, in whom the risk is about 2.5% over lifetime, although prospective studies on large cohorts of patients with large CMN indicate that at least half of melanomas associated with a large CMN have developed within the first 3-5 years of life
Dose: 2.5mg subcutaneous injection, same day each week Expected side effects: Mild nausea (40% of users), decreased appetite, possible fatigue Expected weight loss: 3-5 pounds (mostly water and glycogen initially) Critical actions: Establish meal timing, begin protein tracking, identify your nausea triggers Most users find weeks 1-2 surprisingly manageable
(2025, July 1)
GLP-1 is produced in the intestines, stimulates insulin release, and reduces glucose production by the liver
I was skeptical at first because I had never injected anything before in my life
"GLP-1 medications dont necessarily have a mechanism that breaks down muscle directly